has been classified as an affected listed issuer under Practice Note 17 of the Main Market Listing Requirements of Bursa Malaysia.
Pharmaniaga said it will need to submit a regularisation plan to the Securities Commission Malaysia within 12 months if the plan will result in a significant change in the business direction or policy of the company. “As at the date of this announcement, the company is taking the necessary steps to address its PN17 status.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Singapore Latest News, Singapore Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pharmaniaga now a PN17 company | The Malaysian InsightBursa Malaysia labels firm financially distressed. How on God’s green earth did they do that? They cannot lose but yet…. Just truly Unbelievable. Monopoly also useless. PN MPs dont want to talk about this issue at parliament? 🤔 It has all in 15 senior mgmt consisting of various Chief of..something & President of something, yet it failed absolutely miserably, even with 'big tongkat' from the Gov. Pls replace everyone each of them incld.the BOD. Useless money bleeding agency ! pakatanharapan_
Source: msianinsight - 🏆 8. / 63 Read more »